 Home > Active Ingredient News > Antitumor Therapy > Guidelines Consensus 2022 Guidelines for the diagnosis and treatment of gastric cancer

Guidelines Consensus 2022 Guidelines for the diagnosis and treatment of gastric cancer

 Last Update: 2022-05-25
 Source: Internet
 Author: User

Tags

suez water treatment

enterococcus faecium treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Gastric cancer is a malignant tumor of epithelial origin originating in the stomach

.
According to the latest data from China in 2020, the incidence and mortality of gastric cancer rank third among various malignant tumors
.
There are about 1.
2 million new gastric cancer cases in the world every year, and China accounts for about 40% of them
.
The proportion of early gastric cancer in China is very low, only about 20%.
Most of them are in the advanced stage when they are discovered, and the overall 5-year survival rate is less than 50%
.
In recent years, with the popularization of gastroscopy, the proportion of early gastric cancer has increased year by year
.
In order to further improve the standardization level of gastric cancer diagnosis and treatment, improve the level of gastric cancer diagnosis and treatment in medical institutions, improve the prognosis of gastric cancer patients, and ensure medical quality and medical safety, the website of the National Health and Health Commission released the "Guidelines for the Diagnosis and Treatment of Gastric Cancer (2022 Edition)" on April 11, 2022
.
Here are the main points of the guide:

leave a comment here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.